Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1:4 matched case-control study

Japanese encephalitis (JE), caused by a mosquito-borne flavivirus, is an acute central nervous system infection. An estimated 68,000 cases are reported globally each year, mostly among children [1]. JE is reported commonly in Southern and Eastern Asia including China, Nepal and India. There is no treatment for JE. Vector-control measures are not operationally feasible, are costly and of limited value [2]. It causes significant illness with mortality in almost one-third and similar number of recovered patients experience disability [3].
Source: Journal of Infection and Public Health - Category: International Medicine & Public Health Authors: Source Type: research